missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human CCL25 (TECK) Recombinant Protein, PeproTech®
Click to view available options
Quantité:
1 mg
100 μg
20 μg
250 μg
5 μg
50 μg
500 μg
Conditionnement:
100µg
1mg
20µg
250µg
500µg
50µg
5µg
Description
Recombinant Human TECK is a 14.2 kDa protein containing 127 amino acid residues, including the four conserved cysteine residues present in CC chemokines. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
Chemokines are likely to play an important role in regulating the trafficking of developing T cells within the thymus. Chemokine C-C thymus expressed chemokine (TECK), also designated chemokine ligand 25 (CCL25), small induc-ible cytokine A25, chemokine b-15 or CK b-15, is expressed predominantly in thymic dendritic cells, thymic epithelial cells and in the small intestine. TECK, a CCR9 ligand, has suppressive activity against immature subsets of myeloid progenitors which have been stimulated to proliferate by multiple growth factors. TECK delivers signals through CCR9, which is important for the nav-igation of developing thymocytes. Bone marrow pre-pro-B cells and cells capable of generating pro-B colonies in the presence of interleukin-7 and Flt-3 ligand migrate to TECK, a response lost in later stages of B cell development.
Spécification
Spécification
| Numéro d’adhésion | O15444 |
| À utiliser avec (application) | Control, Western Blot Control, ELISA Standard, Binding Assay, Bioactivity |
| Formule | Protein with no preservative |
| Identification génétique (Entrez) | 6370 |
| Poids moléculaire | 14.2 kDa |
| Nom | Human CCL25 (TECK) |
| Méthode de purification | Purified |
| Quantité | 100 μg |
| Source | E. coli |
| Conditions de stockage | -20°C |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu